Sensorion SA (ALSEN) | Stock Overview & Key Data
Sensorion SA | Small-cap | Healthcare
Sensorion SA | Small-cap | Healthcare
Sensorion SA Performance Comparison
Stock Range
Today's Range
Low: €0.33
High: €0.35
on July 18, 2025
52 Week Range
Low: €0.15
High: €0.97
on April 24, 2025
on September 17, 2024
All-Time High: €19.90 on July 13, 2015
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Market Cap
€107.0M
EPS
-0.09
P/E Ratio (TTM)
-3.63
Forward P/E
-2.52
P/B Ratio
1.36
PEG Ratio
-2.52
Div. Yield
N/A
ROE
-49.28%
Beta
1.133
Debt to Equity
2.93
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
-371.94%
Profit Margin
0.00%
Returns and Earnings
Return on Assets (TTM)
-26.15%
Return on Equity (TTM)
-49.28%
EBITDA
€-27.6M
Net Income (TTM)
€-26.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€0.02
Quarterly Revenue Growth (YoY)
11.90%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Sensorion SA ALSEN | 106.99M Small-cap | 6.45% | -13.16% | 94.12% | -50.00% | -48.44% | -50.75% | -19.51% | -70.54% |
| Medincell S.A MEDCL | 557.56M Mid-cap | -0.25% | -2.79% | 10.57% | -1.36% | -8.78% | 4.03% | 214.96% | 103.05% |
| Abivax SA ABVX | 547.13M Mid-cap | 21.24% | 62.95% | 60.52% | 37.92% | 18.41% | -25.95% | 2.86% | -60.64% |
| Innate Pharma S.A IPH | 145.62M Small-cap | 14.67% | 3.61% | 0.00% | -0.58% | -8.99% | -16.10% | -41.69% | -68.61% |
| Ose OSE | 120.48M Small-cap | 4.93% | 4.52% | -5.84% | -18.78% | -29.35% | -19.03% | -19.27% | -9.83% |
| Transgene S.A TNG | 110.78M Small-cap | -1.27% | -16.13% | 30.00% | 11.43% | 14.71% | -30.36% | -66.67% | -49.02% |
Ownership & Short Interest
Insider Ownership
29.49%
Institutional Ownership
53.64%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
287K
Average 90-Day Volume
420K
Sensorion SA Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Sensorion SA would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ALSEN's 52-week high and low?
- In the last 52 weeks, Sensorion SA reached a high of €0.97 (on September 17, 2024) and a low of €0.15 (on April 24, 2025).
- What is the market cap and P/E ratio for ALSEN?
- Curious about Sensorion SA's size and valuation? Its market capitalization stands at 106.99M. When it comes to valuation, the P/E ratio (trailing twelve months) is -3.63, and the forward P/E (looking ahead) is -2.52.
- Does ALSEN pay dividends? If so, what's the yield?
- As for dividends, Sensorion SA isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Sensorion SA's main competitors or similar companies to consider before investing?
When looking at Sensorion SA, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Medincell S.A
MEDCL557.56M Healthcare Biotechnology 4.03% 214.96% Abivax SA
ABVX547.13M Healthcare Biotechnology -25.95% 2.86% Innate Pharma S.A
IPH145.62M Healthcare Biotechnology -16.10% -41.69% Ose
OSE120.48M Healthcare Biotechnology -19.03% -19.27% Transgene S.A
TNG110.78M Healthcare Biotechnology -30.36% -66.67% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Sensorion SA? (e.g., ROE, Debt/Equity)
- To get a sense of Sensorion SA's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -49.28%, the Debt to Equity ratio from the most recent quarter is 2.93, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for ALSEN?
- Looking at Sensorion SA's growth, its revenue over the trailing twelve months (TTM) was €7M. Compared to the same quarter last year (YoY), quarterly revenue grew by 11.90%, and quarterly earnings saw a YoY growth of N/A.
- How much of ALSEN stock is held by insiders and institutions?
- Wondering who owns Sensorion SA stock? Company insiders (like executives and directors) hold about 29.49% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 53.64%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.